Leishmanin skin test survey in a focus of high endemicity of Leishmania major in Jordan

Acta Tropica ◽  
1993 ◽  
Vol 54 (1) ◽  
pp. 77-79 ◽  
Author(s):  
A.K. Arbaji ◽  
L. Gradoni ◽  
M. Gramiccia
Author(s):  
Thalia Pacheco-Fernandez ◽  
Greta Volpedo ◽  
Sreenivas Gannavaram ◽  
Parna Bhattacharya ◽  
Ranadhir Dey ◽  
...  

Leishmaniasis includes a spectrum of diseases ranging from debilitating cutaneous to fatal visceral infections. This disease is caused by the parasitic protozoa of the genus Leishmania that is transmitted by infected sandflies. Over 1 billion people are at risk of leishmaniasis with an annual incidence of over 2 million cases throughout tropical and subtropical regions in close to 100 countries. Leishmaniasis is the only human parasitic disease where vaccination has been successful through a procedure known as leishmanization that has been widely used for decades in the Middle East. Leishmanization involved intradermal inoculation of live Leishmania major parasites resulting in a skin lesion that following natural healing provided protective immunity to re-infection. Leishmanization is however no longer practiced due to safety and ethical concerns that the lesions at the site of inoculation that can last for months in some people. New genome editing technologies involving CRISPR has now made it possible to engineer safer attenuated strains of Leishmania, which induce protective immunity making way for a second generation leishmanization that can enter into human trials. A major consideration will be how the test the efficacy of a vaccine in the midst of the visceral leishmaniasis elimination program. One solution will be to use the leishmanin skin test (LST) that was also used for decades to determine exposure and immunity to Leishmania. The LST involves injection of antigen from Leishmania in the skin dermis resulting in a delayed type hypersensitivity (DTH) immune reaction associated with a Th1 immune response and protection against visceral leishmaniasis. Reintroduction of novel approaches for leishmanization and the leishmanin skin test can play a major role in eliminating leishmaniasis.


Vaccine ◽  
2006 ◽  
Vol 24 (47-48) ◽  
pp. 6944-6954 ◽  
Author(s):  
Susanne Nylén ◽  
Ali Khamesipour ◽  
Akram Mohammadi ◽  
Reza Jafari-Shakib ◽  
Liv Eidsmo ◽  
...  

2005 ◽  
Vol 111 (4) ◽  
pp. 239-243 ◽  
Author(s):  
A.R. Khabiri ◽  
F. Bagheri ◽  
M.H. Alimohammadian ◽  
M. Assmar ◽  
S.R. Nadaf

Author(s):  
S. Pampiglione ◽  
P.E.C. Manson-Bahr ◽  
M. La Placa ◽  
M.A. Borgatti ◽  
F. Micheloni

2011 ◽  
Vol 12 (1) ◽  
pp. 34-39 ◽  
Author(s):  
Nazar M Abdalla

Objective: This study aimed to identify cases of leishmaniasis in the Nuba Mountain area, which is situated in a unique geographical site located in the centre of Sudanese leishmania belt. Wide range of investigations are available for detection of leishmania cases, but still the most reliable and easy test used as screening and epidemiological tool in field studies needs to be evaluated. The most commonly used conventional diagnostic methods direct microscopy and culture have some drawbacks in diagnosing subclinical cases of leishmaniasis. Materials and methods: In this study, comparative properties of various immune-diagnostic tools with Polymerase Chain Reaction used in sub-clinical leishmaniasis isolates were explored. The immune-diagnostic tools involved in this study include- Leishmanin Skin Test (LST), Enzyme Linked Immunosorbent Assay (ELISA) and Direct Agglutination Test (DAT). The study was conducted in the Green Valley village (Rashad Province, South Kordofan State) with a population of 332. Most of the villagers presented with sub-clinical form of leishmaniasis with minor symptoms and signs without the features found in clinical form of visceral leishmaniasis such as fever, diarrhoea, epistaxis, enlarged lymph nodes, spleen and liver. In this study we collected demographic, clinical and epidemiological data using special questionnaire. Leishmanin skin test (LST), ELISA, DAT and PCR for parasite DNA detection were used. Result: The final positive cases detected by PCR were 32 out of 332 belong to L. donovani species. The final positive cases detected by LST were 51.2% of the total population under study, while 11 out of the 37 tested samples were positive by ELISA. All of the 332 villagers showed negative readings by DAT with exception of three individuals who were positive with very high titers. Conclusion: DNA etxtraction and amplification with primers can be a good screening tool in subclinical leishmaniasis isolates. Keyword: Sub-clinical; Leishmaniasis; Leishmanin Skin Test; ELISA; DAT; PCR. DOI: 10.3329/jom.v12i1.5422J Medicine 2011; 12 : 34-39


Author(s):  
Juan A. Pineda ◽  
Juan Macías ◽  
Francisco Morillas ◽  
Jesús Fernández-Ochoa ◽  
Juan Cara ◽  
...  

1991 ◽  
Vol 44 (3) ◽  
pp. 260-271 ◽  
Author(s):  
Kristen A. Weigle ◽  
Liliana Valderrama ◽  
Alba Lucia Arias ◽  
Cecilia Santrich ◽  
Nancy G. Saravia

Sign in / Sign up

Export Citation Format

Share Document